Press-release for stocks for AMGN

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Published: 2024-02-06 (Crawled : 21:00) - prnewswire.com
BMY | $48.86 -0.27% 0.98% 14M

Health Technology

| -0.81% | O: -0.14% H: 0.35% C: -1.12%
XNCR | $19.02 3.54% 3.57% 760K

Health Technology

| -0.47% | O: -0.05% H: 0.0% C: -2.09%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| 1.97% | O: 1.33% H: 0.0% C: 0.0%
BGNE | $144.12 3.69% 3.48% 190K

Health Technology

| -6.16% | O: -3.53% H: 1.53% C: -0.27%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -13.62% | O: -0.18% H: 0.0% C: -6.22%
year financial results

Global Hairy Cell Leukemia Market Analysis & Forecast 2024-2034
Published: 2024-02-02 (Crawled : 03:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M

Health Technology

| -6.63% | O: -0.5% H: 0.26% C: -1.03%
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -6.28% | O: -0.15% H: 0.0% C: 0.0%
BMY | $48.86 -0.27% 0.98% 14M

Health Technology

| 0.39% | O: 1.23% H: 1.5% C: -1.14%
ABBV | News | $167.8 -1.03% -0.02% 2.9M

Health Technology

| 2.56% | O: 3.59% H: 0.0% C: 0.0%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -15.88% | O: -0.28% H: 0.66% C: -0.14%
cell global leukemia market

AMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
Published: 2024-02-01 (Crawled : 21:00) - prnewswire.com
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -15.88% | O: -0.28% H: 0.66% C: -0.14%
year financial results

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170

Health Technology

| 2.88% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $135.35 -3.53% -4.19% 400

Health Technology

| 3.12% | O: 3.41% H: 0.0% C: -2.45%
VTRS | News A | $11.55 1.67% 1.65% 4.4M

Health Technology

| -2.2% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $98.35 1.1% 0.69% 2.1M

Health Technology

| -8.72% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $40.86 -0.92% 1.25% 1.6M

Health Technology

| 4.53% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $167.8 -1.03% -0.02% 2.9M

Health Technology

| 1.75% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -5.62% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.83 -5.85% -5.99% 370K

Health Technology

| 1.36% | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $71.2 0.49% 0.46% 5.4M

Health Technology

| 5.95% | O: 0.82% H: 0.12% C: -1.64%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -13.23% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc and Amgen Inc to emerge as Some of the Key Companies - Technavio
Published: 2024-01-29 (Crawled : 00:00) - prnewswire.com
CMXHF | $176.0 1.59% -19.21% 960

n/a

| -9.3% | O: -1.84% H: 0.52% C: 0.52%
CSLLY | $90.71 1.73% 3.3% 31K

n/a

| -7.34% | O: -0.25% H: 1.0% C: 0.98%
ALPMF | News | $9.5 -2.56% 43.47% 21K

Health Technology

| -16.3% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | News | $19.54 -3.77% -14.18% 170

Health Technology

| 4.67% | O: 2.93% H: 0.0% C: -1.15%
AZNCF | News | $135.35 -3.53% -4.19% 400

Health Technology

| 2.17% | O: 3.1% H: 0.0% C: -3.91%
ALPMY | News | $9.47 -0.21% -1.11% 400K

Manufacturing

| -18.36% | O: -3.53% H: 3.49% C: 3.4%
TVTX | $5.45 -5.05% -5.13% 940K

Health Technology

| -41.52% | O: -1.39% H: 0.16% C: -1.96%
GSK | News | $40.86 -0.92% 1.25% 1.6M

Health Technology

| 4.61% | O: 0.26% H: 0.13% C: -0.18%
AZN | News | $71.2 0.49% 0.46% 5.4M

Health Technology

| 5.97% | O: 0.24% H: 0.01% C: -0.22%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -12.9% | O: -0.29% H: 0.76% C: 0.67%
companies renal anemia key therapeutics growth market

deCODE genetics: A sequence variant that increases risk of pregnancy loss
Published: 2024-01-29 (Crawled : 10:00) - prnewswire.com
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -12.43% | O: -0.11% H: 0.7% C: 0.65%
pregnancy risk

Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®
Published: 2024-01-29 (Crawled : 09:00) - globenewswire.com
ALVO | $13.54 1.05% 0.74% 190K

n/a

| -7.58% | O: 2.39% H: 4.67% C: 1.67%
KMDA | $5.18 1.57% 1.16% 11K

Health Technology

| -9.58% | O: -1.05% H: 0.41% C: -0.35%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -12.43% | O: -0.11% H: 0.7% C: 0.65%
avt03 prolia biosimilar positive results study

Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published: 2024-01-26 (Crawled : 15:30) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K

Health Technology

| -9.57% | O: -0.27% H: 0.38% C: 0.07%
NVS | News | $98.35 1.1% 0.69% 2.1M

Health Technology

| -8.08% | O: 0.29% H: 0.15% C: -0.13%
SRPT | $124.25 6.09% 5.75% 1.5M

Health Technology

| 3.52% | O: 0.69% H: 0.12% C: -1.75%
GILD | $67.08 0.08% 0.06% 6.2M

Health Technology

| -16.39% | O: 0.0% H: 0.35% C: -0.88%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -12.01% | O: 0.1% H: 0.47% C: 0.39%
market

USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and collaborations are notably driving market growth-17,000+ Technavio Research Reports
Published: 2024-01-22 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -7.4% | O: 1.71% H: 0.0% C: -0.15%
AZNCF | News | $135.35 -3.53% -4.19% 400

Health Technology

| 2.69% | O: 2.63% H: 0.8% C: 0.75%
NVSEF | News | $96.0 0.94% 6.88% 0

Health Technology

| -10.28% | O: 1.4% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 4.4M

Health Technology

| 1.32% | O: -0.18% H: 2.37% C: 2.28%
NVS | News | $98.35 1.1% 0.69% 2.1M

Health Technology

| -9.13% | O: 0.12% H: 0.39% C: 0.1%
ABBV | News | $167.8 -1.03% -0.02% 2.9M

Health Technology

| 2.81% | O: 0.57% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -7.41% | O: -0.21% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M

Health Technology

| 7.0% | O: 1.8% H: 0.14% C: -0.89%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -11.31% | O: 0.29% H: 1.12% C: 0.47%
research growth market

Advancing Melanoma Therapeutics: Global Market Insights and In-depth Analysis by BCC Research
Published: 2024-01-12 (Crawled : 11:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 400

Health Technology

| -1.22% | O: 2.07% H: 0.0% C: -0.06%
ERAS | $1.88 -2.59% -2.66% 530K

| -3.59% | O: 0.0% H: 4.62% C: -1.03%
NVS | News | $98.35 1.1% 0.69% 2.1M

Health Technology

| -8.6% | O: -0.16% H: 0.43% C: 0.02%
AZN | News | $71.2 0.49% 0.46% 5.4M

Health Technology

| 2.92% | O: 0.25% H: 0.36% C: 0.1%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -9.93% | O: 0.71% H: 0.56% C: 0.42%
melanoma research global market

Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published: 2024-01-09 (Crawled : 03:00) - prnewswire.com
ALPMF | News | $9.5 -2.56% 43.47% 21K

Health Technology

| -23.14% | O: 0.16% H: 0.0% C: -3.88%
NVSEF | News | $96.0 0.94% 6.88% 0

Health Technology

| -9.65% | O: -0.24% H: 0.0% C: 0.0%
ALPMY | News | $9.47 -0.21% -1.11% 400K

Manufacturing

| -22.88% | O: -1.22% H: 0.0% C: -0.72%
NVS | News | $98.35 1.1% 0.69% 2.1M

Health Technology

| -8.15% | O: -0.46% H: 0.74% C: -0.19%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -7.93% | O: 0.74% H: 0.0% C: 0.0%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -12.18% | O: -0.92% H: 0.63% C: -0.25%
america cancer treatment market

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
SWTX | $43.38 -1.41% -1.45% 500K

Health Technology

| 14.28% | O: -1.58% H: 11.22% C: 11.16%
BGNE | $144.12 3.69% 3.48% 190K

Health Technology

| -12.86% | O: 0.36% H: 3.65% C: 3.35%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -9.9% | O: -0.5% H: 3.18% C: 3.12%
conference therapeutics

Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170

Health Technology

| 1.69% | O: 2.46% H: 0.0% C: 0.0%
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -7.71% | O: 0.49% H: 0.6% C: -0.83%
AZNCF | News | $135.35 -3.53% -4.19% 400

Health Technology

| -1.24% | O: 0.15% H: 1.88% C: -1.17%
NVSEF | News | $96.0 0.94% 6.88% 0

Health Technology

| -8.57% | O: -0.24% H: 1.43% C: 1.43%
NVS | News | $98.35 1.1% 0.69% 2.1M

Health Technology

| -6.84% | O: 0.32% H: 0.93% C: 0.38%
GSK | News | $40.86 -0.92% 1.25% 1.6M

Health Technology

| 4.58% | O: -0.36% H: 0.98% C: 0.72%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -6.99% | O: -0.14% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M

Health Technology

| 3.52% | O: -0.68% H: 0.87% C: 0.1%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -9.95% | O: -0.32% H: 0.44% C: 0.26%
america cancer immunotherapy market

Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-04 (Crawled : 22:00) - biospace.com/
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -9.21% | O: 0.27% H: 1.19% C: 0.55%
conference pipeline

Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
Published: 2024-01-04 (Crawled : 13:00) - globenewswire.com
THRD | $11.33 2.53% 2.73% 160K

| 6.09% | O: 1.59% H: 3.13% C: 2.4%
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -9.21% | O: 0.27% H: 1.19% C: 0.55%
business update financial

AMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Published: 2024-01-03 (Crawled : 21:00) - prnewswire.com
AMGN | News | $273.01 -0.19% -0.17% 1.5M

Health Technology

| -9.21% | O: 0.27% H: 1.19% C: 0.55%
conference

AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS® (SOTORASIB)
Published: 2023-12-26 (Crawled : 14:00) - prnewswire.com
BGNE | $144.12 3.69% 3.48% 190K

Health Technology